Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-8-23
pubmed:abstractText
Chronic anal fissure (CAF) is a painful condition that is unlikely to resolve with conventional conservative management. Previous studies have reported that topical treatment of CAF with glyceryl trinitrate (GTN) reduces pain and promotes healing, but optimal treatment duration is unknown.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1128-045X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-8
pubmed:meshHeading
pubmed-meshheading:20632059-Administration, Topical, pubmed-meshheading:20632059-Adult, pubmed-meshheading:20632059-Analysis of Variance, pubmed-meshheading:20632059-Chronic Disease, pubmed-meshheading:20632059-Dose-Response Relationship, Drug, pubmed-meshheading:20632059-Drug Administration Schedule, pubmed-meshheading:20632059-Female, pubmed-meshheading:20632059-Fissure in Ano, pubmed-meshheading:20632059-Follow-Up Studies, pubmed-meshheading:20632059-Humans, pubmed-meshheading:20632059-Male, pubmed-meshheading:20632059-Middle Aged, pubmed-meshheading:20632059-Nitroglycerin, pubmed-meshheading:20632059-Pain Measurement, pubmed-meshheading:20632059-Prospective Studies, pubmed-meshheading:20632059-Reference Values, pubmed-meshheading:20632059-Risk Assessment, pubmed-meshheading:20632059-Severity of Illness Index, pubmed-meshheading:20632059-Time Factors, pubmed-meshheading:20632059-Treatment Outcome, pubmed-meshheading:20632059-Wound Healing
pubmed:year
2010
pubmed:articleTitle
Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial.
pubmed:affiliation
Italian Society of ColoRectal Surgery (SICCR) Coloproctology Unit of Rome, Rome, Italy. gagliarg@yahoo.com
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study